Updates are available Correction dated 2023-11-22
Click to view Correction: https://doi.org/10.1007/s10384-023-01025-3
-
Authors
Sakata, Rei
Mizoue, Shiro
Yoshikawa, Keiji
Adachi, Misato
Ohkubo, Shinji
Hamada, Naoki
Naito, Tomoko
Muramatsu, Tomoyuki
Hara, Takeshi
Asato, Ryo
Aihara, Makoto https://orcid.org/0000-0001-6810-0583
-
Funding
Funding for this research was provided by:
Senju Pharmaceutical Co., Ltd
- License Information
-
More Information
Article History
Received: 19 January 2023
Accepted: 6 July 2023
First Online: 19 August 2023
Change Date: 22 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10384-023-01025-3
Declarations
:
: R. Sakata, Grant (Santen, Novartis, TOMEY); S. Mizoue, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Kowa, Novartis, Otsuka Pfizer); K. Yoshikawa, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Otsuka, Novartis, RE Medical), M. Adachi, None; S. Ohkubo, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Pfizer, Viatris, Alcon, JFC Sales Plan, Beeline, Nitto Medic, Sucampo, ZEISS, JFC, Heidelberg Engineering, Otsuka); N. Hamada, None; T. Naito, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Otsuka, Novartis, Kowa); T. Muramatsu, None; T. Hara, None; R. Asato, None; M. Aihara, Consulting fees (Santen, Senju, Alcon, Pfizer, Kowa, Otsuka, Wakamoto, Glaukos, HOYA, IRIDEX, Astellas), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Senju, Alcon, Pfizer, Kowa, Otsuka, Wakamoto, Glaukos, HOYA, IRIDEX, Astellas, CANON, ZEISS).
